157 related articles for article (PubMed ID: 26081329)
21. [Comparative study of alpha-lipoic acid and mexidol effects on affective status, cognitive functions and quality of life in diabetes mellitus patients].
Volchegorskiĭ IA; Rassokhina LM; Koliadich MI; Alekseev MI
Eksp Klin Farmakol; 2011; 74(11):17-23. PubMed ID: 22288155
[TBL] [Abstract][Full Text] [Related]
22. [Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
Zhuravleva MV; Kamchatnov PR; Vasyukova NS; Arkhipov VV; Kuznetsova EV; Kameneva TR; Serebrova SY
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):29-39. PubMed ID: 36440774
[TBL] [Abstract][Full Text] [Related]
23. [The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].
Loskutnikov MA; Domashenko MA; Vakin TM; Trushina IA; Konstantinov VI; Proskuryakova OS; Shchukina EP
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):22-26. PubMed ID: 33244953
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy of the use of antioxidant preparation mexidol in comprehensive treatment of inflammatory diseases of parodontium].
Garazha NN; Garus IaN; Ivashova AV; Sakuro AA
Stomatologiia (Mosk); 2006; 85(6):19-21. PubMed ID: 17310943
[TBL] [Abstract][Full Text] [Related]
25. [Improvement of the efficacy of treatment of hypertensive encephalohathy by using mexidol].
Bolotova EV; Lushpay NY; Kovrigina IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):61-64. PubMed ID: 29863694
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)].
Stakhovskaya LV; Mkhitaryan EA; Tkacheva ON; Ostroumova TM; Ostroumova OD
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8. Vyp. 2):49-57. PubMed ID: 33016677
[TBL] [Abstract][Full Text] [Related]
27. [The system stress-limiting action of mexidol in chronic cerebral ischemia].
Antipenko EA; Derugina AV; Gustov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):28-31. PubMed ID: 27240044
[TBL] [Abstract][Full Text] [Related]
28. [The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis].
Zakharov VV; Vakhnina NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):82-88. PubMed ID: 38261288
[TBL] [Abstract][Full Text] [Related]
29. [The efficacy of mexidol for transient ischemic attacks in the vertebrobasilar system in elderly patients with chronic cerebral ischemia].
Abramenko YV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9. Vyp. 2):42-48. PubMed ID: 30499559
[TBL] [Abstract][Full Text] [Related]
30. [Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of stroke].
Karpov SM; Morozova MY; Muravyov KA; Vyshlova IA; Kantemirova FS
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3. Vyp. 2):59-62. PubMed ID: 35318844
[TBL] [Abstract][Full Text] [Related]
31. [The possibility of treatment of cognitive impairment in the complex therapy of patients with the consequences of cerebral infarction].
Kuznetsova EB; Salina EA; Sholomov II
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):103-106. PubMed ID: 26978058
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of Mexidol in patients with type 2 diabetes mellitus with neurological complications].
Pugacheva EL
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(5):84-89. PubMed ID: 35611905
[TBL] [Abstract][Full Text] [Related]
33. [Adaptogenic effects of mexidol in chronic cerebral ischemia].
Antipenko EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):44-9. PubMed ID: 22677755
[TBL] [Abstract][Full Text] [Related]
34. [Effect of semax and mexidol on brain ischemia models in rats].
Iasnetsov VV; Voronina TA
Eksp Klin Farmakol; 2009; 72(1):68-70. PubMed ID: 19334516
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy of antioxidant treatment with mexidol forte in 250 patients with chronic cerebral venous insufficiency].
Chukanova EI; Chukanova AS; Mamaeva KI
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3):57-63. PubMed ID: 33834719
[TBL] [Abstract][Full Text] [Related]
36. [The use of mexidol in psychiatric practice].
Kosenko VG; Karagezian EA; Luneva LV; Smolenko LF
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):38-41. PubMed ID: 16841482
[TBL] [Abstract][Full Text] [Related]
37. [Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome].
Volchegorskiĭ IA; Moskvicheva MG; Chashchina EN
Ter Arkh; 2005; 77(10):10-5. PubMed ID: 16320677
[TBL] [Abstract][Full Text] [Related]
38. [The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels].
Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Smirnov LD; Gatsura VV
Eksp Klin Farmakol; 1997; 60(4):22-4. PubMed ID: 9376750
[TBL] [Abstract][Full Text] [Related]
39. [The influence of mexidol on post-radiation recovery of hemopoietic system].
Moroz BB; Deshevoĭ IuB; Sukoian GV; Voronina TA; Lyrshchikova AV; Lebedev VG
Radiats Biol Radioecol; 2009; 49(1):90-6. PubMed ID: 19368329
[TBL] [Abstract][Full Text] [Related]
40. [Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].
Gorbunov AA; Gan'shina TS; Turilova AI; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):23-7. PubMed ID: 22232910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
